[Effect of the depot estrogen ethinyl estradiol sulfonate on the composition of human milk].
56 healthy mothers were treated orally with an oestrogen (3 mg ethinyloestradiol-sulfonat) for inhibition of lactation. We found no effect on milk constituents (12 parameters). These results are discussed.
D000135:Acid Phosphatase / Q000097:blood; D000410:Alanine Transaminase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000032:analysis; D002241:Carbohydrates / Q000032:analysis; D004573:Electrolytes / Q000032:analysis; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects; D008055:Lipids / Q000032:analysis; D008895:Milk, Human / Q000032:analysis* / Q000201:enzymology; D011247:Pregnancy; D011506:Proteins / Q000032:analysis
D002241:Carbohydrates; D004573:Electrolytes; D008055:Lipids; D011506:Proteins; D004997:Ethinyl Estradiol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D005634:Fructose-Bisphosphate Aldolase
Zum Einfluss des Depotöstrogens Athinylöstradiolsulfonat auf die Zusammensetzung der Frauenmilch